Pharmacy Times August 20, 2024

Brandon Newman discusses the significant influence of the “big 3” pharmacy benefit managers and the key legislative and regulatory efforts around transparency.

Brandon Newman, founder and CEO of Xevant, delves into the complex landscape of pharmacy benefits managers (PBMs) and the regulatory environment surrounding the industry. Newman highlights the outsized influence of the “big 3” PBMs, which control over 80% of pharmacy utilization, and how their practices impact the cost and access for both patients and pharmacies. He discusses the key legislative efforts at the state and federal levels, focusing on the push for greater transparency in reimbursement rates, business practices, and fees. He also emphasizes the role of innovative, smaller PBMs in offering unique value propositions, such as high-service...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations, Trends
Walgreens to go private in $10B deal
The pharmacy change 'key to your future existence as a health plan'
Healthcare & Life Sciences Private Equity Deal Tracker: Sycamore Partners to Acquire Walgreens
How Pharmacy Deserts are Being Defined, Identified
Sun Pharma buys Checkpoint and its new cancer drug

Share This Article